RxDoctor Payments Data

William Haas, MD

Family Medicine · Lutz, FLNPI 1467424408

Payments from drug & device makers

$378in general payments, 2019–2025

Across 21 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$108
  • Pfizer$78
  • Lilly USA, LLC$30
  • AbbVie$30
  • GSK$29
  • Abbott$25
  • plus $78 from 4 others

What the payments were for

  • Food & beverage$378100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk5$108
Pfizer5$78
Lilly USA, LLC2$30
AbbVie2$30
GSK2$29
Abbott1$25
Bayer1$24
Si-bone, Inc.1$20
UCB, Inc.1$19
Boston Scientific1$15

How this compares

$378 in reported general payments places this provider in the 45th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$133,680
Medicare patients
323
Services billed
1,259

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide90$80,365
EliquisApixaban54$62,559
JardianceEmpagliflozin41$58,154
XareltoRivaroxaban25$23,261
JanuviaSitagliptin Phosphate17$18,512
FarxigaDapagliflozin Propanediol16$18,274
Atorvastatin Calcium775$7,038
Rosuvastatin Calcium501$6,266
Metoprolol Succinate231$2,888
Levothyroxine Sodium287$2,756
Amlodipine Besylate424$2,611
Duloxetine Hcl96$2,397
Lisinopril344$2,250
Losartan Potassium246$2,155
Metformin Hcl288$1,509

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$108$80,36590 claims
PfizerEliquis$78$62,55954 claims
AbbVieSynthroid$30$87415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Lutz

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →